International safety notice
Pseudoephedrine – Risks of PRES and RCVS
Ireland / HPRA · IRL · Feb 9, 2024
Key facts
| Title | Pseudoephedrine – Risks of PRES and RCVS |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Pseudoephedrine – Risks of PRES and RCVS |
| Models | 1.25MG, 2.5MG, 220044, 120MG, 200MG, PA0074, PA0126, PA0891, 120MGPROLONGED, PA0979, PA0330, PA0678 and 1 more |
| Date | Feb 9, 2024 |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
- 1–9 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1